Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26036 http://scihub22266oqcxt.onion/10.1002/jmv.26036 32437004!7280725!32437004     free     free     free       J+Med+Virol 2020 ; 92 (10): 1818-1824 Nephropedia Template TP {{tp|p=32437004|t=2020. Hepatic complications of COVID-19 and its treatment |pdf=|usr=}}{{32437004}} gab.com Text Hepatic complications of COVID-19 and its treatment JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32437004 #FOAvip Coronavirus disease 2019 (COVID-19) is highly contagious and has a variety of clinical manifestations, it can affect a number of other organs in addition to the lungs, and liver injury may occur. Severe acute respiratory syndrome coronavirus 2 can cause liver injury through systemic inflammatory response syndrome, cytokine storms, ischemia-reperfusion injury, side effects of treatment drugs, and underlying liver disease and can attack liver cells directly via angiotensin-converting enzyme 2. Clinical studies have found that liver injury in COVID-19 patients mainly manifests as abnormal liver biochemical indicators, but there have been no reports of liver failure caused by this disease. The number of COVID-19 patients with liver injury is increasing, and the incidence of liver injury in COVID-19 patients with severe disease are higher than in patients with mild disease. Liver injury may be a risk factor, which worsens in patients with COVID-19, and hence it is necessary to pay attention to the occurrence of liver injury in the diagnosis and treatment of COVID-19. Twit Text FOAVip Hepatic complications of COVID-19 and its treatment ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32437004 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32437004 #FOAvip English Wikipedia <ref>{{Cite pmid|32437004}}</ref> Hepatic complications of COVID-19 and its treatment #MMPMID32437004 Tian D; Ye Q J Med Virol 2020[Oct]; 92 (10): 1818-1824 PMID32437004show ga Coronavirus disease 2019 (COVID-19) is highly contagious and has a variety of clinical manifestations, it can affect a number of other organs in addition to the lungs, and liver injury may occur. Severe acute respiratory syndrome coronavirus 2 can cause liver injury through systemic inflammatory response syndrome, cytokine storms, ischemia-reperfusion injury, side effects of treatment drugs, and underlying liver disease and can attack liver cells directly via angiotensin-converting enzyme 2. Clinical studies have found that liver injury in COVID-19 patients mainly manifests as abnormal liver biochemical indicators, but there have been no reports of liver failure caused by this disease. The number of COVID-19 patients with liver injury is increasing, and the incidence of liver injury in COVID-19 patients with severe disease are higher than in patients with mild disease. Liver injury may be a risk factor, which worsens in patients with COVID-19, and hence it is necessary to pay attention to the occurrence of liver injury in the diagnosis and treatment of COVID-19. |Animals[MESH] |COVID-19/*complications/virology[MESH] |Humans[MESH] |Liver Diseases/*drug therapy/*etiology/virology[MESH] |Liver/drug effects/virology[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/complications/virology[MESH]Hepatic complications of COVID-19 and its treatment (epmc).pdf DeepDyve Pubget Overpricing